期刊文献+

GST-β-catenin-His双标签融合蛋白的原核表达、纯化及鉴定 被引量:4

Prokaryotic expression,purification,and identification of GST-β-catenin-His double labeled fusion protein
下载PDF
导出
摘要 应用RT-PCR技术扩增β-catenin的cDNA序列,并且在基因下游引入6×His标签序列,克隆至表达载体pGEX-4T-1.经测序鉴定后,将重组质粒转入BL21pLysS感受态细菌,经IPTG诱导表达,采用Glutathione Sepharose 4B和Ni柱分步纯化GST-β-catenin-His融合蛋白.所得产物经SDS-PAGE检测,在114 kDa处显示特异条带,与GST-β-catenin-His融合蛋白预期分子量相符.经Western Blotting鉴定,所纯化蛋白能被β-catenin抗体、GST抗体和His抗体识别,为进一步研究β-catenin的功能提供了基础和前提. The cDNA sequence of β-catenin was amplified through RT-PCR with 6xHis tag added in the gene downstream,cloned into the vector pGEX-4T-1.The plasmid transformed into BL21 pLysS was induced by IPTG.The induced fusion protein was purified stepwise using Glutathione Sepharose 4B and Ni columns.The final protein ran on SDS-PAGE with a specific band at the expected size of 114 kDa.Western Blotting showed that the purified protein can be recognized by the anti-β-catenin,anti-GST,and anti-His antibodies,respectively.All these results provide a basis for further study of β-catenin function.
作者 尹会龙 袁莉
出处 《中国科学院研究生院学报》 CAS CSCD 北大核心 2012年第6期847-852,共6页 Journal of the Graduate School of the Chinese Academy of Sciences
基金 国家自然科学基金(Y11101L1A1) 中国科学院研究生院院长基金(095101GN00)资助
关键词 Β-连环蛋白 纯化 GST-His双标签 Western BLOTTING β-catenin purification GST and His tags Western Blotting
  • 相关文献

参考文献3

二级参考文献12

  • 1Min Su~1 Shan-Ming Lu~1 Dong-Ping Tian~1 Hu Zhao~1 Xiao-Yun Li~2 De-Rui Li~3 Zhi-Chao Zheng~4 1 Department of Pathology,2 Tumor Hospital,3,4 Second Teaching Hospital,Shantou University Medical College,Shantou 515031,China.Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China[J].World Journal of Gastroenterology,2001,7(5):657-661. 被引量:20
  • 2W.Michael Korn Division of Gastroenterology and Comprehensive Cancer Canter,University of California San Francisco,San Francisco,CA 94143-0128,USA.Moving toward an understanding of the metastatic process in hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(6):777-778. 被引量:13
  • 3Ying-ChengLin,Ming-YaoWu,De-RuiLi,Xian-YingWu,Rui-MingZheng.Prognostic and clinicopathological features of E-cadherin,α-catenin,β-catenin,γ-catenin and cyclin D_1 expression in human esophageal squamous cell carcinoma[J].World Journal of Gastroenterology,2004,10(22):3235-3239. 被引量:30
  • 4Polakis P.Wnt signaling and cancer.Genes Dev,2000,14(15):1837-1851.
  • 5Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.Oncoloby,2000,59(4):302-309.
  • 6Bienz M,Clevers H.Linking colorectal cancer to Wnt signaling.Cell,2000,103(2):311-320.
  • 7Bankfalvi A,Terpe HJ,Breukelmann D,et al.Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression:a comparative study with CD44.Histopathology,1999,34(1):25-34.
  • 8Lim SC,Lee MS.Significance of E-cadherin/beta-catenin complex and cyclinD1 in breast cancer.Oncol Rep,2002,9(5):915-928.
  • 9Lopez-Knowles E,Zardawi SJ,McNeil CM,et al.Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.Cancer Epidemiol Biomarkers Prev,2010,19(1):301-309.
  • 10Chung GG,Zerkowski MP,Ocal IT,et al.Beta-catenin and p53 analyses of a breast carcinoma tissue microarray.Cancer,2004,100(10):2084-2092.

共引文献33

同被引文献31

  • 1李永进,陈媛媛,毕利军.融合标签技术及其应用[J].生物工程学报,2006,22(4):523-527. 被引量:20
  • 2Cosmi B, Palareti G. Old and new heparins. Thrombosis Re- search. 2012, 129(3): 388-391.
  • 3Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharma- cokineties, Dosing, Monitoring, Effieany, and Safety. Chest, 2001, 119(1 suppl) : 64S-94S.
  • 4Wei Z, Deakin. JA, Blaum BS, et al. Preparation of heparin/ heparan sulfate oligosaccharides with internal N-unsubstituted glu- eosamine residues for functional studies. Glycoconj J, 2011, 28 (8-9) : 525-535.
  • 5Venkataraman G, Shriver Z, Raman R, et al. Sequencing com- plex polysaccharides. Science, 1999 Oct 15, 286 ( 5439 ) : 537- 542.
  • 6Linhardt R J, Cooney CL, Tapper D, et al. An immobilized mi- crobial heparinase for blood deheparinization. Appl Biochem Bio- technol, 1984, 9 ( 1 ) : 41-55.
  • 7Chen Y, Xing XH, Lou K. Construction of recombinant Esche- richia coli for over production of soluble heparinase I by fusion to maltose binding protein. Biochem Eng J, 2005, 23 (2) : 155- 159.
  • 8Huang J, Cao L, Guo W, et al. Enhanced soluble expression of recombination Flavobacterium heparinum heparinase I in Esche- richia coli by fusing it with various soluble partners. Protein ex- pression and Purification, 2012, 83(2): 169-176.
  • 9Pryor KD, Leiting B. High-level expression of soluble protein in Escherichia coli using a His6-Tag and maltose-bingding-protein double-Affinity fusion system. Protein Expr Purif, 1997, 10(3 ) : 309-319.
  • 10赵静,丁丽华,仇玮祎,牛畅,陈力权,甘纯玑,叶棋浓.GST-His双标签原核表达载体的构建及应用[J].生物技术通讯,2009,20(4):520-522. 被引量:3

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部